Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Microarray analysis makes strong showing in miscarriage testing
August 2016
SHARING OPTIONS:

IRVINE, Calif.—CombiMatrix Corp. has announced the publication of data from a retrospective study showing a high success rate and superior diagnostic power of chromosomal microarray analysis for recurrent pregnancy loss testing. The company analyzed more than 8,000 consecutive products of conception samples, with results obtained successfully for more than 90 percent of the cases, compared to success rates of 60 to 80 percent for samples evaluated with the standard approach of karyotyping.
 
“Our high success rate with evaluating challenging POC samples includes both fresh and formalin-fixed, paraffin-embedded samples, thus providing significant advantages and options to clinicians and providers. Further, the ability of single nucleotide polymorphism-based microarray analysis to identify aneuploidy, polyploidy, whole-genome homozygosity, segmental genomic imbalances and maternal cell contamination maximizes sensitivity and decreases the number of false-negative results,” commented study author Dr. Trilochan Sahoo, CombiMatrix’s vice president of clinical affairs and director of cytogenetics.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.